A breakthrough for moms and babies. Preeclampsia can be unpredictable — and in some cases, life-threatening. But now, a new FDA-cleared blood test can help doctors predict the risk within two weeks, giving families answers sooner and helping prevent unnecessary early deliveries. This innovation is changing how preeclampsia is detected and managed — supporting healthier outcomes for moms and their babies: go.roche.com/Preeclampsia_Blood_Test | Roche Diagnostics USA

Roche Diagnostics

Just in: The COVID-19 At-Home Test that tens of millions of Americans received via the U.S. government is now available over-the-counter nationwide under the new Pilot name and brand. http://bit.ly/3UrlhCC | Roche Diagnostics USA